Potentiation of clopidogrel active metabolite formation by rifampicin leads to greater P2Y12 receptor blockade and inhibition of platelet aggregation after clopidogrel

Autor: JUDGE, H.M., PATIL, S.B., BUCKLAND, R.J., JAKUBOWSKI, J.A., STOREY, R.F. *
Zdroj: In Journal of Thrombosis and Haemostasis August 2010 8(8):1820-1827
Databáze: ScienceDirect
Externí odkaz: